In NAFLD patients, the increased TG secretion in VLDL is evident by the increased blood serum VLDL concentrations and upregulated expression of ApoB100 and MTP [62]. The gene discussed is APOB; the disease is metabolic dysfunction-associated steatotic liver disease.